Key result
Mesenchymal stem cell transplantation improves left ventricular systolic pressure and contraction velocity after myocardial infarction.
In Brief Objective The present study was to determine the effects of mesenchymal stem cell (MSC) transplantation into ischemic myocardium on left ventricular (LV) function and remodeling, especially the changes in extracellular matrix (ECM) and in transforming growth factor (TGF)-β1 after myocardial infarction (MI). Methods In this study, we investigated the changes in ECM involving collagen type I, collagen type III, matrix metalloproteinase (MMP)-1, tissue inhibitor of matrix metalloproteinase (TIMP)-1 and in TGF-β1 mRNA expressions by using reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization after MSC transplantation into infarcted myocardium in rats. Protein expressions were detected by immunohistochemistry and western blot. Seven and 28 days after coronary artery ligation, hemodynamic evaluations were performed. Results Heart : body weight ratio in the MI+MSC group decreased after MSC transplantation into infarcted myocardium compared with the MI group. However, LV systolic pressure (LVSP) and LV peak velocities of contraction and relaxation (+dP/dtmax and –dP/dtmax) significantly increased compared with the MI group (P<0.01). There was marked up-regulation of mRNA transcription for ECM and TGF-β1 proteins in MI rats. Immunohistochemical and western blot studies confirmed that the expressions of these ECM and TGF-β1 proteins were significantly increased in the MI group. The mRNA and protein expressions of collagen type I, collagen type III, TIMP-1 and TGF-β1 were all decreased by MSC transplantation in our study, although no significant difference was found for the mRNA and protein expressions of MMP-1 between the MI group and the MI+MSC group. Conclusions Our results demonstrated that MSC transplantation could inhibit LV remodeling and improve heart function. To determine the effects of mesenchymal stem cell (MSC) transplantation into ischemic myocardium on left ventricular (LV) function and remodeling, we investigated the changes in collagen type I, collagen type III, MMP-1, TIMP-1, TGF-β1mRNA and protein expressions after MSC transplantation into infarcted myocardium in rats. Seven and 28 days after coronary artery ligation, hemodynamic evaluations were performed. LV systolic pressure (LVSP) and LV peak velocities of contraction and relaxation (+dP/dtmax and −dP/dtmax) significantly increased in the MI+MSC group compared with the MI group (P≤0.01).The mRNA and protein expressions of collagen type I, collagen type III, TIMP-1 and TGF-β1 were all decreased by MSC transplantation in our study, although no significant difference was found in them RNA and protein expressions of MMP-1 between the MI group and the MI+MSC group. Our results demonstrated that MSC transplantation could inhibit LV remodeling and improve heart function.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2005) studied Myocardial infarction. Mesenchymal stem cell (MSC) transplantation vs. Myocardial infarction without MSC transplantation was evaluated on Left ventricular function (LV systolic pressure and peak velocities of contraction/relaxation) and extracellular matrix protein expression (p=≤0.01). Mesenchymal stem cell transplantation into infarcted rat myocardium significantly increased left ventricular systolic pressure and peak velocities of contraction and relaxation (P≤0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: